ATE466938T1 - Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs - Google Patents

Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs

Info

Publication number
ATE466938T1
ATE466938T1 AT00918373T AT00918373T ATE466938T1 AT E466938 T1 ATE466938 T1 AT E466938T1 AT 00918373 T AT00918373 T AT 00918373T AT 00918373 T AT00918373 T AT 00918373T AT E466938 T1 ATE466938 T1 AT E466938T1
Authority
AT
Austria
Prior art keywords
prostate
prostate cancer
pcgem1
prevention
detection
Prior art date
Application number
AT00918373T
Other languages
English (en)
Inventor
Vasantha Srikantan
Zhiqiang Zou
Judd W Moul
Shiv Srivastava
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Application granted granted Critical
Publication of ATE466938T1 publication Critical patent/ATE466938T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT00918373T 1999-03-26 2000-03-24 Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs ATE466938T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12646999P 1999-03-26 1999-03-26
PCT/US2000/007906 WO2000058470A1 (en) 1999-03-26 2000-03-24 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer

Publications (1)

Publication Number Publication Date
ATE466938T1 true ATE466938T1 (de) 2010-05-15

Family

ID=22425000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918373T ATE466938T1 (de) 1999-03-26 2000-03-24 Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs

Country Status (7)

Country Link
EP (1) EP1185639B1 (de)
JP (1) JP4942248B2 (de)
AT (1) ATE466938T1 (de)
AU (1) AU778088B2 (de)
CA (1) CA2368385C (de)
DE (1) DE60044350D1 (de)
WO (1) WO2000058470A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7019498A (en) 1997-04-10 1998-10-30 Diagnocure Inc. Pca3, pca3 genes, and methods of use
US6828429B1 (en) 1999-03-26 2004-12-07 Henry M. Jackson Foundation For The Advancement Of Military Medicine Prostate-specific gene, PCGEM1, and the methods of using PCGEM1 to detect, treat, and prevent prostate cancer
ES2260059T3 (es) 1999-09-29 2006-11-01 Diagnocure Inc. Rna mensajero del pca3 en tejidos benignos y malignos de prostata.
EP1344064A2 (de) * 2000-11-01 2003-09-17 Diadexus, Inc. Zusammensetzungen und verfahren bezüglich prostata-spezifischen genen und proteinen
US20030175707A1 (en) * 2000-11-06 2003-09-18 Yongming Sun Compositions and methods relating to prostate specific genes and proteins
AU2002235164A1 (en) * 2000-11-06 2002-05-21 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
WO2002042329A2 (en) * 2000-11-21 2002-05-30 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
AU2002217991A1 (en) * 2000-11-21 2002-06-03 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
US20020155463A1 (en) * 2000-12-01 2002-10-24 Zairen Sun Prostate polynucleotides and uses
GB0119852D0 (en) * 2001-08-15 2001-10-10 Univ York Baculovirus
WO2003042370A2 (en) 2001-11-14 2003-05-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services New gene expressed in prostate cancer and methods of use
WO2003089596A2 (en) * 2002-04-19 2003-10-30 Schering Aktiengesellschaft Novel prostate tumor-specific promoter
AU2004209578A1 (en) 2003-02-07 2004-08-19 Diagnocure Inc. Method to detect prostate cancer in a sample
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0462145T3 (da) 1989-03-07 1994-08-08 Genentech Inc Covalente konjugater mellem lipid og oligonucleotid
KR920702409A (ko) 1989-10-24 1992-09-04 원본미기재 새로운 결합을 갖는 올리고뉴클레오티드 유사체
US5830686A (en) * 1994-01-13 1998-11-03 Calydon Tissue-specific enhancer active in prostate
WO1999000498A1 (en) * 1997-06-27 1999-01-07 Human Genome Sciences, Inc. Human nk-3 related prostate specific gene-1

Also Published As

Publication number Publication date
DE60044350D1 (de) 2010-06-17
AU3919600A (en) 2000-10-16
CA2368385A1 (en) 2000-10-05
JP4942248B2 (ja) 2012-05-30
AU778088B2 (en) 2004-11-18
JP2003521236A (ja) 2003-07-15
EP1185639A1 (de) 2002-03-13
EP1185639B1 (de) 2010-05-05
WO2000058470A1 (en) 2000-10-05
CA2368385C (en) 2012-05-15

Similar Documents

Publication Publication Date Title
EA200501772A1 (ru) Способы измерения экспрессии генов из фиксированного и залитого в парафин образца ткани
WO2003009814A3 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
WO2003004989A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2002101075A9 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
WO2004000094A8 (en) Predictive markers in cancer therapy
ATE419516T1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
WO2003000012A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
AU2003293141A1 (en) Methods for identifying risk of breast cancer and treatments thereof
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
MX9801264A (es) Control de la expresion del gen de cd44 para uso terapeutico.
WO2002055735A3 (en) Compositions and methods relating to prostate specific genes and proteins
WO2004005530A3 (en) Compositions and methods for treatment and detection of multiple cancers
WO2003030725A3 (en) Pancreatic cancer diagnosis and therapies
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
WO2002044419A3 (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
DE60039453D1 (de) Pin1 als stadiumsmarker der aggressivität und/oder der metastasierung abnormale zellwachstum
WO2002042463A3 (en) Compositions and methods relating to prostate specific genes and proteins
DK0950062T3 (da) Proteinmarkörer for esophageal cancer
WO2002039431A3 (en) Compositions and methods relating to prostate specific genes and proteins
WO2002042776A3 (en) Compositions and methods relating to prostate specific genes and proteins
BR0012301A (pt) Inibidores de crescimento de células epiteliais
WO2004048548A3 (en) Methods for identifying risk of breast cancer and treatments thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties